• Users Online: 833
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe News Contacts Login 
REVIEW ARTICLE
Year : 2017  |  Volume : 1  |  Issue : 1  |  Page : 22-35

Updates in vascular dementia


1 Department of Psychiatry, Hospital Universitario Basurto, Bilbao; Department of Neuroscience, University of the Basque Country, Leioa, Bizkaia, Spain
2 Department of Psychiatry, Hospital Universitario Basurto, Bilbao, Spain
3 Department of Psychiatry, The University of Illinois at Chicago, Chicago, Illinois, USA

Correspondence Address:
Nora Olazabal Eizaguirre
Pabellón Eskuza, Hospital Basurto, Avenida Montevideo 18, 48013 Bilbao, Bizkaia
Spain
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/hm.hm_4_16

Rights and Permissions

It has been more than a hundred years since Alzheimer and Binswanger's first description of vascular dementia (VaD). Ever since then, histopathology research and neuroimaging techniques have allowed the development of new pathogenic, etiologic, and treatment hypotheses. The “vascular cognitive impairment (VCI)” concept has also been developed, and it includes all grades of cognitive dysfunction of a vascular origin. Early detection of dementia as well as its primary prevention is the main goals for clinicians. For this reason, new scales, new diagnostic criteria, and preventive treatments have been proposed. The association between stroke and VaD is already known, but a comprehensive review of this relationship reveals a bidirectional causality. Depression has been hypothesized as a risk factor for later dementia development. Late-life depression is the most associated condition; however, studies have found it works as a prodromal state symptom. Deep knowledge in vascular risk factors that are involved in vascular origin cognitive decline is the most important prevention tool. Hypertension, Type II diabetes, cholesterol, and inflammation markers have demonstrated to increase the risk of VaD. Evidence supporting treatments for primary and secondary prevention of VaD and VCI are presented.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed6771    
    Printed392    
    Emailed0    
    PDF Downloaded648    
    Comments [Add]    

Recommend this journal